Yep, broad coverage about the guy in 10 yr remission. CarT will be on everyone's radar. Bodes well for PTX with our tech being licenced from the founder of CarT, UPenn. Peter Mac Centre gets involved in this article with the ABC's interviewing CAR T-cell clinical trial investigator and leader of the aggressive lymphoma disease group.....
https://www.abc.net.au/news/science/2022-02-03/leukaemia-car-t-cell-therapy-immunotherapy-immune-system-cancer/100794750
Yep, broad coverage about the guy in 10 yr remission. CarT will...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
-0.001(2.50%) |
Mkt cap ! $31.40M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.1¢ | 3.9¢ | $72.73K | 1.802M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 436541 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 560576 | 1 |
View Market Depth
| Last trade - 15.59pm 15/11/2024 (20 minute delay) ? |
| PTX (ASX) Chart |